Brief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
11/06/2026 12:04
BRIEF-Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application June 11 (Reuters) - Medicenna Therapeutics Corp MDNA.TO:
MEDICENNA THERAPEUTICS - ANNOUNCES TWO NEW U.S. PATENTS AND ONE ALLOWED U.S. PATENT APPLICATION
Source text: ID:nGNX95n3F9
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results